Active ingredientNadifloxacinCat. No. P-N002-001CAS 124858-35-1Family · Pharmaceutical analytical standards
Nadifloxacin
An antibiotic of the fluoroquinolone family designed only for use on the skin, as a cream or ointment: it blocks bacterial DNA gyrase and was introduced in Japan in 1993 for acne and other bacterial skin infections. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Applied to the skin it reaches the blood only in tiny amounts: over the next 48 hours only about 0.09% of the dose turns up in the urine, which is why it acts almost only where it is spread.
Go to the active ingredient →Active ingredientNadifloxacinCat. No. P-N002-001CAS 124858-35-1
Isotopically labelledNadifloxacin-d9Cat. No. P-N002-002CAS 2714421-20-0
Impurity(R)-NadifloxacinCat. No. P-N002-005CAS 160961-35-3
ImpurityNadifloxacin Impurity 1Cat. No. P-N002-006CAS 80076-46-6
Impurity5,6-Difluoro-2-methylquinolineCat. No. P-N002-007CAS 80076-50-2
Impurity8-Bromo-5,6-difluoro-2-methylquinolineCat. No. P-N002-008CAS 131190-82-4
ImpurityNadifloxacin Impurity 2Cat. No. P-N002-009CAS 87488-29-7
ImpurityNadifloxacin Impurity 3Cat. No. P-N002-010CAS 130539-72-9
ImpurityNadifloxacin Impurity 4Cat. No. P-N002-011
ImpurityS-NadifloxacinCat. No. P-N002-015CAS 154357-42-3
ImpurityS-Nadifloxacin SulfateCat. No. P-N002-016No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.